ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Beatrice Mintz Appointed to Pontifical Academy; Three Americans Asked to Help Shanghai Group

November 28, 1986

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Senate Confirms McClellan For FDA

October 25, 2002